GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 80 filers reported holding GRITSTONE ONCOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.63 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $42,845 | -11.8% | 24,910 | 0.0% | 0.00% | – |
| Q2 2023 | $48,575 | -23.0% | 24,910 | +9.8% | 0.00% | – |
| Q1 2023 | $63,050 | -26.8% | 22,680 | -9.1% | 0.00% | – |
| Q4 2022 | $86,078 | +34.5% | 24,950 | 0.0% | 0.00% | – |
| Q3 2022 | $64,000 | +6.7% | 24,950 | 0.0% | 0.00% | – |
| Q2 2022 | $60,000 | -40.0% | 24,950 | +3.0% | 0.00% | – |
| Q1 2022 | $100,000 | -45.4% | 24,212 | +69.9% | 0.00% | – |
| Q4 2021 | $183,000 | – | 14,252 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 4,450,638 | $41,970,000 | 8.18% |
| Copernicus Capital Management, LLC | 37,000 | $349,000 | 5.64% |
| EcoR1 Capital, LLC | 3,421,287 | $32,263,000 | 1.43% |
| Palo Alto Investors LP | 2,298,382 | $21,674,000 | 1.24% |
| AlpInvest Partners B.V. | 226,866 | $2,139,000 | 1.06% |
| Stenahm Asset Managment Ltd | 150,000 | $1,415,000 | 1.00% |
| FRAZIER MANAGEMENT LLC | 1,030,878 | $9,721,000 | 0.78% |
| BVF INC/IL | 1,861,239 | $17,551,000 | 0.66% |
| Avidity Partners Management LP | 2,122,064 | $20,011,000 | 0.55% |
| Redmile Group, LLC | 2,448,158 | $23,086,000 | 0.32% |